FDA Sues NJ Compounder Over Mold-Contaminated Products

Law360, New York (June 25, 2013, 7:14 PM EDT) -- The U.S. Food and Drug Administration on Friday slapped drug compounding facility Med Prep Consulting Inc. and its senior executive with a lawsuit in New Jersey federal court for circulating intravenous medicines infected with mold and for failing to secure proper approval for some of its medications.

The government is seeking a permanent injunction to cease all of Med Prep's operations until its distribution methods are improved. The allegations stem from a Med Prep recall in March following the discovery of mold in several of its...
To view the full article, register now.